PRV Transfer Agreement by and between Biohaven Pharmaceutical Holding Ltd and GW Research, Ltd.PRV Transfer Agreement • May 8th, 2019 • Gw Pharmaceuticals PLC • Pharmaceutical preparations • New York
Contract Type FiledMay 8th, 2019 Company Industry JurisdictionThis letter will be presented to FDA as evidence that GW acknowledges the sale and transfer of the Voucher from GW to Biohaven.
PRV TRANSFER AGREEMENT BY AND BETWEEN BIOHAVEN PHARMACEUTICAL HOLDING LTD AND GW RESEARCH, LTD. March 15, 2019PRV Transfer Agreement • March 18th, 2019 • Biohaven Pharmaceutical Holding Co Ltd. • Pharmaceutical preparations • New York
Contract Type FiledMarch 18th, 2019 Company Industry JurisdictionThis PRV TRANSFER AGREEMENT (this “Agreement”) is made and entered into as of March 15, 2019 (the “Effective Date”), by and between Biohaven Pharmaceutical Holding Ltd, including its Affiliates (collectively “Buyer”) and GW Research, Ltd., including its Affiliates (collectively, “Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.